Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades
- PMID: 20809186
- DOI: 10.1007/s12032-010-9660-7
Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades
Abstract
The purpose of this study is to determine whether the expressions of MMP-7 and MMP-14 are associated with the ERK 1/2 signaling pathway in human brain gliomas of different pathological grades. Immunohistochemistry and western blot methods were used to determine the expressions of MMP-7, MMP-14 and the phosphorylation status of ERK1/2 in 73 cases of human brain glioma specimens and two cases of normal brain tissues. Results indicated that the protein expression levels of MMP-7, MMP-14 and ERK1/2 phosphorylation level were all elevated with the increasing pathological grades in brain glioma tissues, and correlation assay indicated that the level of ERK1/2 phosphorylation was positively correlated with protein expression levels of MMP-7 and MMP-14 in gliomas of different pathological grades respectively. Moreover, the impact of ERK1/2 inhibitor U0126 on the expressions of MMP-7 and MMP-14 was examined in human U87 glioma cells by western blot analysis. The expressions of MMP-7 and MMP-14 were significantly decreased in human U87 glioma cells after treatment with ERK1/2 inhibitor U0126. The above results suggest that the expressions of MMP-7 and MMP-14 may be associated with activation of ERK1/2 signaling pathway in human brain gliomas of different pathological grades.
Similar articles
-
Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.J Korean Med Sci. 2000 Jun;15(3):309-14. doi: 10.3346/jkms.2000.15.3.309. J Korean Med Sci. 2000. PMID: 10895974 Free PMC article.
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.J Neurosurg. 1995 Aug;83(2):298-307. doi: 10.3171/jns.1995.83.2.0298. J Neurosurg. 1995. PMID: 7616276
-
Matrix metalloproteinase-7 and epidermal growth factor receptor mediate hypoxia-induced extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase activation and subsequent proliferation in bladder smooth muscle cells.In Vitro Cell Dev Biol Anim. 2006 May-Jun;42(5-6):124-33. doi: 10.1290/0510070.1. In Vitro Cell Dev Biol Anim. 2006. PMID: 16848631
-
The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.Brain Tumor Pathol. 2003;20(2):65-72. doi: 10.1007/BF02483449. Brain Tumor Pathol. 2003. PMID: 14756443
-
The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.J Neurooncol. 2001 Jun;53(2):213-35. doi: 10.1023/a:1012280925031. J Neurooncol. 2001. PMID: 11716072 Review.
Cited by
-
MT1-MMP Expression Levels and Catalytic Functions Dictate LDL Receptor-Related Protein-1 Ligand Internalization Capacity in U87 Glioblastoma Cells.Int J Mol Sci. 2022 Nov 17;23(22):14214. doi: 10.3390/ijms232214214. Int J Mol Sci. 2022. PMID: 36430705 Free PMC article.
-
Effects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cells.Int J Mol Med. 2018 Mar;41(3):1339-1348. doi: 10.3892/ijmm.2017.3334. Epub 2017 Dec 20. Int J Mol Med. 2018. PMID: 29286066 Free PMC article.
-
Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.Clin Transl Oncol. 2013 Feb;15(2):139-45. doi: 10.1007/s12094-012-0900-5. Epub 2012 Jul 19. Clin Transl Oncol. 2013. PMID: 22855183
-
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.Oncotarget. 2015 Apr 20;6(11):9140-59. doi: 10.18632/oncotarget.3274. Oncotarget. 2015. PMID: 25823818 Free PMC article.
-
Nidogen-1 expression is associated with overall survival and temozolomide sensitivity in low-grade glioma patients.Aging (Albany NY). 2021 Mar 18;13(6):9085-9107. doi: 10.18632/aging.202789. Epub 2021 Mar 18. Aging (Albany NY). 2021. PMID: 33735110 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous